Skip to content

Diagnostic performance of Glt25D1 to significant liver injury for subjects with chronic HBV infection

Diagnostic performance of Glt25D1 to significant liver injury for ALT normal subjects with chronic HBV infection

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800018023
Enrollment
Unknown
Registered
2018-08-27
Start date
2018-09-01
Completion date
Unknown
Last updated
2018-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sunject with chronic HBV infection

Interventions

Gold Standard:Liver biopsy and pathological examination
1) the grading of liver injury was evaluated by modified Knodell score
2) the staging of fibrosis was evaluated by modified Metavir score.
Index test:serum&#32
Glt25D1&#32
(ELISA)
&#32
(FibroaScan)

Sponsors

Beijing Ditan Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients with chroninc HBV infection; 2. Age 18-60 years old; 3. Clinical examination follow-up records showed continued normal liver function; 4. The history of HBV infection was more than 10 years; 5. Sign informed consent; 6. Consent to liver biopsy. 7. No severe organ dysfunction or failure; 8. Normal coagulation function.

Exclusion criteria

Exclusion criteria: 1. Contraindications for liver biopsy; 2. There are other hepatoviral infections or other chronic liver diseases, including non-alcoholic fatty liver disease, alcoholic and non-alcoholic hepatitis, drug-induced liver injury, and autoimmune liver diseases,et al.; 3. Chronic systemic disease with liver involvement; 4. Abnormal coagulation function; 5. There are other clinical conditions not suitable for liver puncture.

Design outcomes

Primary

MeasureTime frame
serum Glt25D1;liver biopsy and pathological diagnosis;

Countries

China

Contacts

Public ContactHongshan Wei

Beijing Ditan Hospital, Capital Medical University

drwei@ccmu.edu.cn+86 13810033129

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026